CASSAVA SCIENCES INC (SAVA)
US14817C1071 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 41.12M | N/A -100.00% | N/A | N/A | 911.17M | 1.268B 39.16% | |||||||||||||
| EBITDA YoY % growth | 31.37M | -14.28M -139.62% | -15.3M -14.24% | -24.48M -4.65% | -13.26M 20.26% | -12.079M 44.64% | -11.224M 25.91% | N/A -39.92% | N/A -376.03% | 165.16M -143.19% | N/A -32.66% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 31.37M | N/A -139.62% | N/A -14.24% | -20.553M -5.35% | N/A 20.12% | N/A 44.27% | -5.78M 25.53% | -5.664M -37.10% | -32.564M -383.38% | -83.98M -143.44% | -108.426M -32.41% | -148.971M -40.60% | -31.11M 79.12% | -123.42M -296.72% | -4.08M 96.69% | -3.468M 15.00% | 263.67M 7,702.94% | 565.59M 114.51% | |
| Operating Margin | 76.29% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 28.94% | 44.60% | |
| EPS YoY % growth | 4.76 | -2.14 -145.00% | -2.50 -16.67% | -2.68 4.76% | -1.94 18.57% | N/A | -0.32 | -0.21 20.94% | -0.82 -224.00% | -2.03 -134.57% | -2.39 -22.11% | -1.11 52.30% | -0.44 59.91% | 0.10 122.99% | -1.91 -1,970.00% | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -0.40 19.42% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -34.731M -52.40% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.58 4.92% | -0.90 | 0.32 | 35.38% |
| Q2 2024 Q2Q % growth | 0.13 120.63% | -0.41 | 0.54 | 131.86% |
| Q1 2024 Q2Q % growth | 0.58 200.00% | -0.47 | 1.05 | 223.61% |
| Q4 2023 Q2Q % growth | -0.50 -6.38% | -0.53 | 0.03 | 5.73% |
| Q3 2023 Q2Q % growth | -0.61 -19.61% | -0.79 | 0.18 | 22.83% |
| Q2 2023 Q2Q % growth | -0.63 -31.25% | -0.60 | -0.03 | -4.69% |
| Q1 2023 Q2Q % growth | -0.58 -31.82% | -0.57 | -0.01 | -2.46% |
| Q4 2022 Q2Q % growth | -0.47 -34.29% | -0.57 | 0.10 | 17.72% |
| Q3 2022 Q2Q % growth | -0.51 -112.50% | -0.49 | -0.02 | -4.71% |
| Q2 2022 Q2Q % growth | -0.48 -269.23% | -0.44 | -0.04 | -8.81% |
| Q1 2022 Q2Q % growth | -0.44 -388.89% | -0.42 | -0.02 | -3.95% |
| Q4 2021 Q2Q % growth | -0.35 -288.89% | -0.34 | -0.01 | -2.43% |
| Q3 2021 Q2Q % growth | -0.24 -300.00% | -0.15 | -0.09 | -56.86% |
| Q2 2021 Q2Q % growth | -0.13 -160.00% | -0.13 | 0.00 | 0.43% |
| Q1 2021 Q2Q % growth | -0.09 -80.00% | -0.10 | 0.01 | 11.76% |
| Q4 2020 Q2Q % growth | -0.09 -12.50% | -0.05 | -0.04 | -85.76% |
| Q3 2020 Q2Q % growth | -0.06 -50.00% | -0.07 | 0.01 | 11.77% |
| Q2 2020 Q2Q % growth | -0.05 16.67% | -0.06 | 0.01 | 18.30% |
| Q4 2019 Q2Q % growth | -0.08 | -0.13 | 0.05 | 39.67% |
| Q3 2019 Q2Q % growth | -0.04 | -0.14 | 0.10 | 70.95% |
| Q2 2019 Q2Q % growth | -0.06 83.33% | -0.11 | 0.05 | 43.98% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 13.19% | 38.7% | 38.7% |
| Revenue | N/A | N/A | N/A | N/A |